GPC5, a tumor suppressor, is regulated by miR-620 in lung adenocarcinoma

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2540-2546

  Zhao, Zhengyuan ^a   Han, Chengguang ^a   Liu, Juntao ^a   Wang, Changlei ^a   Wang, Y I ^a   Cheng, Liya ^a  

^a MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

Author keywords

Cell growth; Cell invasion; GPC5; Lung adenocarcinoma; miR 620

Indexed keywords

GLYPICAN; MICRORNA; MICRORNA 620; UNCLASSIFIED DRUG; GPC5 PROTEIN, HUMAN; MIRN620 MICRORNA, HUMAN; TUMOR SUPPRESSOR PROTEIN;

3' UNTRANSLATED REGION; ADULT; ARTICLE; BINDING SITE; CANCER CELL LINE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GPC5 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; MIDDLE AGED; PHENOTYPE; RNA BINDING; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; AGED; CANCER GRADING; CANCER STAGING; CELL MOTION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LUNG TUMOR; PATHOLOGY; RNA INTERFERENCE; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGED; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYPICANS; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RNA INTERFERENCE; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

EID: 84899678612     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2092     Document Type: Article

References (28)

1. Subramaniam S, Thakur RK, Yadav VK, Nanda R, Chowdhury S and Agrawal A: Lung cancer biomarkers: State of the art. J Carcinog 12: 3, 2013.
2. Amorin Kajatt E: Lung cancer: a review of current knowledge, diagnostic methods and therapeutic perspectives. Rev Peru Med Exp Salud Publica 30: 85-92, 2013 (In Spanish).
3. Li Y, Sheu CC, Ye Y, et al: Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol 11: 321-330, 2010.
4. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Brennecke J, Hipfner DR, Stark A, Russell RB and Cohen SM: Bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113: 25-36, 2003. (Pubitemid 36411957)
6. Xu P, Vernooy SY, Guo M and Hay BA: The Drosophila microRNA Mir-14 suppresses cell death and is required for normal fat metabolism. Curr Biol 13: 790-795, 2003. (Pubitemid 36531030)
7. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
8. Chen CZ, Li L, Lodish HF and Bartel DP: MicroRNAs modulate hematopoietic lineage differentiation. Science 303: 83-86, 2004. (Pubitemid 38055775)
9. Eads CA, Danenberg KD, Kawakami K, et al: MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 28: E32, 2000.
10. Filmus J, Capurro M and Rast J: Glypicans. Genome Biol 9: 224, 2008.
11. Filmus J, Church JG and Buick RN: Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine. Mol Cell Biol 8: 4243-4249, 1988.
12. Filmus J, Shi W, Wong ZM and Wong MJ: Identification of a new membrane-bound heparan sulphate proteoglycan. Biochem J 311: 561-565, 1995.
13. Paine-Saunders S, Viviano BL and Saunders S: GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13. Genomics 57: 455-458, 1999. (Pubitemid 29239237)
14. Veugelers M, De Cat B, Ceulemans H, et al: Glypican-6, a new member of the glypican family of cell surface heparan sulfate proteoglycans. J Biol Chem 274: 26968-26977, 1999.
15. Kleeff J, Ishiwata T, Kumbasar A, et al: The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 102: 1662-1673, 1998. (Pubitemid 28516251)
16. Matsuda K, Maruyama H, Guo F, et al: Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 61: 5562-5569, 2001. (Pubitemid 32694943)
17. Nakatsura T, Kageshita T, Ito S, et al: Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res 10: 6612-6621, 2004. (Pubitemid 39346558)
18. Saikali Z and Sinnett D: Expression of glypican 3 (GPC3) in embryonal tumors. Int J Cancer 89: 418-422, 2000.
19. Reardon DA, Jenkins JJ, Sublett JE, Burger PC and Kun LK: Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma. Pediatr Neurosurg 32: 187-191, 2000. (Pubitemid 30665909)
20. Ojopi EP, Rogatto SR, Caldeira JR, Barbiéri-Neto J and Squire JA: Comparative genomic hybridization detects novel amplifications in fibroadenomas of the breast. Genes Chromosomes Cancer 30: 25-31, 2001.
21. Neat MJ, Foot N, Jenner M, et al: Localisation of a novel region of recurrent amplification in follicular lymphoma to an approximately 6.8 Mb region of 13q32-33. Genes Chromosomes Cancer 32: 236-243, 2001. (Pubitemid 32953977)
22. Du L, Schageman JJ, Subauste MC, et al: miR-93, miR-98, and miR-197 regulate expression of tumor suppressor gene FUS1. Mol Cancer Res 7: 1234-1243, 2009.
23. Liu ZL, Wang H, Liu J and Wang ZX: MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 372: 35-45, 2013.
24. Garofalo M, Di Leva G, Romano G, et al: miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 16: 498-509, 2009.
25. Ebi H, Sato T, Sugito N, et al: Counterbalance between RB inactivation and miR-17-92 overexpression in reactive oxygen species and DNA damage induction in lung cancers. Oncogene 28: 3371-3379, 2009.
26. Hayashita Y, Osada H, Tatematsu Y, et al: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 65: 9628-9632, 2005. (Pubitemid 41541436)
27. Veugelers M, Vermeesch J, Reekmans G, Steinfeld R, Marynen P and David G: Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family. Genomics 40: 24-30, 1997. (Pubitemid 27108243)
28. Yu W, Inoue J, Imoto I, Matsuo Y, Karpas A and Inazawa J: GPC5 is a possible target for the 13q31-q32 amplification detected in lymphoma cell lines. J Hum Genet 48: 331-335, 2003. (Pubitemid 36834363)